Search

Your search keyword '"*CYCLOSERINE"' showing total 5,462 results

Search Constraints

Start Over You searched for: Descriptor "*CYCLOSERINE" Remove constraint Descriptor: "*CYCLOSERINE"
5,462 results on '"*CYCLOSERINE"'

Search Results

1. Copper inactivates DcsB by oxidizing the metal ligand Cys86 to sulfinic acid.

2. Pharmacokinetics of anti-TB drugs in children and adolescents with drug-resistant TB: a multicentre observational study from India.

4. A Rare Case of Tremor Induces by Cycloserine in Drug-Resistant Tuberculosis Patient.

5. Role of Glutamatergic Modulators in the Treatment of Obsessive Compulsive and Related Disorders

6. Nine months of bedaquiline, linezolid, levofloxacin, clofazimine, and cycloserine chemotherapy for rifampicin/multidrug-resistant tuberculosis: a multicenter, randomized, open-label non-inferiority trial in China.

7. Impaired Hippocampal Long-Term Potentiation and Memory Deficits upon Haploinsufficiency of MDGA1 Can Be Rescued by Acute Administration of D-Cycloserine.

8. NMDA antagonist agents for the treatment of symptoms in autism spectrum disorder: a systematic review and meta-analysis.

9. Dopamine D1 Receptor Agonists Rescue Age-related Decline in Temporal Order Memory.

10. Role of Glutamatergic Modulators in the Treatment of Obsessive Compulsive and Related Disorders.

11. Evaluation of Three Different Selective Media for Enumeration of Clostridium perfringens in Untreated and Treated Wastewater.

12. Fabrication of nanocrystal forms of ᴅ-cycloserine and their application for transdermal and enteric drug delivery systems

13. Pharmacotherapy to Improve Cognitive Functioning After Acquired Brain Injury: A Meta‐Analysis and Meta‐Regression.

14. NRX-101 (D-Cycloserine + Lurasidone) Is Active against Drug-Resistant Urinary Pathogens In Vitro.

15. NMDA antagonist agents for the treatment of symptoms in autism spectrum disorder: a systematic review and meta-analysis

16. Randomized controlled experimental study of hydrocortisone and D-cycloserine effects on fear extinction in PTSD.

17. Cycloserine- and Fluoroquinolone-Induced Seizure in Multidrug-Resistance Tuberculosis (MDR-TB) Patient: A Case Report

18. Effects of chronic haloperidol treatment on the expression of fear memory and fear memory extinction in the cued fear‐conditioned rats.

19. Multi-faceted Anti-obesity Effects of N-Methyl-D-Aspartate (NMDA) Receptor Modulators: Central-Peripheral Crosstalk.

20. Effect of erythropoietin on cognitive side-effects of electroconvulsive therapy in depression: A randomized, double-blind, placebo-controlled trial.

21. Pramipexole Enhances Reward Learning by Preserving Value Estimates.

22. Predicting drug–target binding affinity with cross-scale graph contrastive learning.

23. Administration of oxathridine, a first‐in‐class histamine‐3 receptor partial agonist in healthy male volunteers: Central nervous system depression and pseudo‐hallucinations.

24. The GlyT1-inhibitor Org 24598 facilitates the alcohol deprivation abolishing and dopamine elevating effects of bupropion + varenicline in rats.

25. Cycloserine- and Fluoroquinolone-Induced Seizure in Multidrug-Resistant Tuberculosis (MDR-TB) Patient: A Case Report.

26. Enhancing Fear Extinction: Pharmacological Approaches

27. Sleep quality and outcome of exposure therapy in adults with social anxiety disorder

28. NRX-101 (D-cycloserine plus lurasidone) vs. lurasidone for the maintenance of initial stabilization after ketamine in patients with severe bipolar depression with acute suicidal ideation and behavior: a randomized prospective phase 2 trial

29. Case report on cycloserine serum levels after treatment with oral terizidone and oral cycloserine

30. Comparative functional and structural analysis of Pseudomonas aeruginosad‐alanine–d‐alanine ligase isoforms as prospective antibiotic targets.

31. A Single-Run HPLC–MS Multiplex Assay for Therapeutic Drug Monitoring of Relevant First- and Second-Line Antibiotics in the Treatment of Drug-Resistant Tuberculosis.

32. Short-active gestational photoperiod reduces effortful choice behavior in mice, partial normalization by d-amphetamine.

33. The effect of SSRIs on fear learning: a systematic review and meta-analysis.

34. The Distractor Positivity Component and the Inhibition of Distracting Stimuli.

35. Electronic excitation of ethanol by low-energy electron impact.

36. NRX-101 (D-cycloserine plus lurasidone) vs. lurasidone for the maintenance of initial stabilization after ketamine in patients with severe bipolar depression with acute suicidal ideation and behavior: a randomized prospective phase 2 trial.

37. Using pre-treatment de novo threat conditioning outcomes to predict treatment response to DCS augmentation of exposure-based CBT.

38. Pediatric phase 2 trial of a WEE1 inhibitor, adavosertib (AZD1775), and irinotecan for relapsed neuroblastoma, medulloblastoma, and rhabdomyosarcoma.

39. Unconditioned and conditioned anxiolytic effects of Sodium Valproate on flavor neophobia and fear conditioning.

40. Reinstatement of nicotine conditioned place preference in a transgenerational model of drug abuse vulnerability in psychosis: Impact of BDNF on the saliency of drug associations.

41. Cycloserine-induced psychosis in patients with drug-resistant tuberculosis: a systematic review of case reports

43. Allosteric modulation of GluN1/GluN3 NMDA receptors by GluN1-selective competitive antagonists.

44. VU0155041, a positive allosteric modulator of mGluR4, in the nucleus accumbens facilitates extinction and inhibits the reinstatement of morphine-induced conditioned place preference in male rats.

45. New Role of D-Cycloserine: Shorten Adaptation Process and Extend Maintenance Time of Motion Sickness.

46. Mechanism of D-Cycloserine Inhibition of D-Amino Acid Transaminase from Haliscomenobacter hydrossis.

47. The effect of TRV027 on coagulation in COVID-19: A pilot randomized, placebo-controlled trial.

48. Infant Exposure to Antituberculosis Drugs via Breast Milk and Assessment of Potential Adverse Effects in Breastfed Infants: Critical Review of Data.

49. An α7 nAChR approach for the baseline-dependent modulation of deviance detection in schizophrenia: A pilot study assessing the combined effect of CDP-choline and galantamine.

50. NRX-101 (D-Cycloserine + Lurasidone) Is Active against Drug-Resistant Urinary Pathogens In Vitro

Catalog

Books, media, physical & digital resources